Nasal T/NK Cell Lymphoma: A Clinico Pathologic Study of 30 West Chinese Patients with Special Reference to Proliferation and Apoptosis

References

• McBride P. Photographs of a case of rapid destruction of the nose and face. J. Laryngol. 1897; 12: 64–73
   Google Scholar
• Abbondanzo S. L., Wenig B. M. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophe-notypic study of 120 cases. Cancer 1995; 75: 1281–91
   PubMed Web of Science ®Google Scholar
• Frierson H. F., Innes D. J., Mills S. E., Wick M. R. Immunophenotypic analysis of sinonasal non-Hodgkin's lymphomas. Hum. Pathol. 1989; 20: 636–642
   PubMed Web of Science ®Google Scholar
• Fellbaum C., Hansmann M. L., Lennert K. Malignant lymphomas of the nasal cavity and paranasal sinuses. Virchows Arch. (Pathol. Anat.). 1989; 414: 399–405
   Web of Science ®Google Scholar
• Chan J. K., Ng C. S., Lo S. T. Immunohistological characterization of malignant lymphomas of the Waldeyer's ring other than the nasopharynx. Histopathology 1987; II: 885–99
   Web of Science ®Google Scholar
• Arber D. A., Weiss L. M., Albujar P. F., Chen Y. Y., Jaffe E. S. Nasal lymphomas in Peru: high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J. Surg. Pathol. 1993; 17: 392–399
   PubMed Web of Science ®Google Scholar
• Ho F. C. S., Choy D., Loke S. L., Kung I. T., Fu K. H., Liang R., Todd D., Khoo R. K. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases and immunophenotypic studies of 16 cases. Hum. Pathol. 1990; 21: 1041–1050
   PubMed Web of Science ®Google Scholar
• Chott A., Rappersberger K., Schlossarek W., Radaszkiewicz T. Peripheral T cell lymphoma presenting primarily as lethal midline granuloma. Hum. Pathol. 1988; 19: 1093–101
   PubMed Web of Science ®Google Scholar
• Ihii Y., Yamanaka N., Ogawa K., Yoshida Y., Takami T., Matsuura A., Isago H., Kataura A., Kikuchi K. Nasal T-cell lymphoma as a type of so-called ‘lethal midline Granuloma’. Cancer 1982; 50: 2336–2344
   PubMed Web of Science ®Google Scholar
• Lippman S. M., Grogan T. M., Spier C. M., Koopmann C. J., Gall E. P., Shimm D. S., Durie B. G. Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer 1987; 59: 936–9
   PubMed Web of Science ®Google Scholar
• Ng C. S., Chan J. K., Lo S. T. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum. Pathol. 1987; 18: 1257–62
   PubMed Web of Science ®Google Scholar
• De Bruin P. C., Kummer J. A., Van Der Valk P., Van Heerde P., Kluin P. M., Willemze R., Ossenkoppele G. J., Radaszkiewicz T., Meijer C. J. Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. Blood 1994; 84: 3785–91
   PubMed Web of Science ®Google Scholar
• Aozasa K., Ohsawa M., Tomita Y., Tagawa S., Yamamura T. Polymorphic reticulosis is a neoplasm of large granular lymphocytes with CD3+ phenotype. Cancer 1995; 75: 894–901
   PubMed Web of Science ®Google Scholar
• Jaffe E. S., Chan J. K. C., Su I.-J., Frizzera G., Mori S., Feller A. C., Ho F. C. S. Report of the workshop on nasal and related extranodal angiocentric T/Natural Killer cell lymphomas: Definitions, differential diagnosis, and epidemiology. Am. J. Surg. Pathol. 1996; 20: 103–111
   PubMed Web of Science ®Google Scholar
• Jaffe E. S. Nasal and nasal-type T/NK cell lymphoma: a unique form of lymphoma associated with the Epstein-Barr virus. Histopathol. 1995; 27: 581–583
   PubMed Web of Science ®Google Scholar
• Mann W. J., Riede U. N., Bocking A. Midline malignant reticulosis. Acta. Otolaryngol. Stochh. 1984; 97: 365–372
   PubMed Web of Science ®Google Scholar
• Aozasa K., Ohsawa M., Tajima K., Sasaki R., Maeda H., Matsunaga T., Friedmann I. Nation-wide study of lethal mid-line granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int. J. Cancer 1989; 44: 63–6
   PubMed Web of Science ®Google Scholar
• De Bruin P. C., Jiwa M., Oudjaus J. J., Van Der Valk P., Van Heerde P., Sabourin J. C., Csanaky G., Gaulard P., Noorduyn A. L., Willemze R., Ossenkoppel G. J., Radaszkiewicz T., Meijer C. J. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994; 83: 1612–1218
   PubMed Web of Science ®Google Scholar
• Furukawa M., Sakashita H., Kimura Y., Umeda R. Association of Epstein-Barr virus with polymorphic reticulosis. Eur. Arch. Otorhinolaryngol. 1990; 247: 261–3
   PubMed Web of Science ®Google Scholar
• Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., Osato T. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128–30
   PubMed Web of Science ®Google Scholar
• Chen Y. K., Yip T. T., Tsang W. Y., Ng C. S., Lau W. H., Poon Y. F., Wong C. C., Ma V. W. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am. J. Surg. Pathol. 1994; 18: 938–946
   PubMed Web of Science ®Google Scholar
• Zhou X. G., Hamilton D. S., Yan Q. H., Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 1994; 24: 115–22
   PubMed Web of Science ®Google Scholar
• Mishima K., Horiuchi K., Kojya S., Takahashi H., Ohsawa M., Aozasa K. Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. Cancer 1994; 73: 3041–6
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Lescs M. C., Briere J. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688–2695
   PubMed Web of Science ®Google Scholar
• Borisch B., Hennig I., Laeng R. H., Waelti E. R., Kraft R., Laissue J. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993; 82: 858–64
   PubMed Web of Science ®Google Scholar
• Tsang W. Y., Chan J. K., Yip T. T., Ng C. S., Wong K. F., Poon Y. F., Ma V. W. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Hum. Pathol. 1994; 25: 758–65
   PubMed Web of Science ®Google Scholar
• Lipford E. H., Margolick J. B., Longo D. L., Fauci A. S., Jaffe E. S. Angiocentric immunoproliferative lesions: a clinico-pathologic spectrum of post-thymic T-cell proliferations. Blood 1988; 72: 1674–1681
   PubMed Web of Science ®Google Scholar
• Stamenkovic L, Toccanier M. F., Kapanci Y. Polymorphic reticulosis (lethal midline granuloma) and lymphomatoid granulomatosis: identical or distinct entities?. Virchows Arch. Pathol. Anat. 1981; 390: 81–91
   PubMedGoogle Scholar
• Guinee D., Jaffe E. S., Kingma D., Fishback N., Wallberg K., Krishnan J., Frizzera G., Travis W., Koss M. Pulmonary lymphomatoid granulomatosis: evidence of Epstein-Barr virus infected B-lymphocytes with a predominant T-cell component and vasculitis. Am. J. Surg. Pathol. 1994; 18: 753–64
   PubMed Web of Science ®Google Scholar
• Hall P. A., Levison D. A. Assessment of cellular proliferation in histological material. J. Clin. Pathol. 1990; 43: 184–192
   PubMed Web of Science ®Google Scholar
• Gerdes J., Li L., Schlueter C., Duchrow M., Wohlenberg C., Gerlach C., Stahmer I., Kloth S., Brandt E., Flad H. D. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol. 1991; 138: 867–873
   PubMed Web of Science ®Google Scholar
• Sawhney N., Hall P. A. Ki67—structure, function and new antibodies. J. Pathol. 1992; 168: 161–161
   PubMed Web of Science ®Google Scholar
• McCormick D., Chong H., Hobbs C., Datta C., Hall P. A. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 1993; 22: 355–60
   PubMed Web of Science ®Google Scholar
• Key G., Becker M. H. G., Baron B., Duckrow M., SchlÜTer C., Flad H. D., Gerdes J. New Ki-67-equivalent murine antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 66 bp repetitive elements encoding for the Ki-67 epitope. Lab. Invest. 1993; 68: 629–635
   PubMed Web of Science ®Google Scholar
• Wyllie A. H. Apoptosis (the 1992 Frank Rose Memorial Lecture). Br. J. Cancer 1993; 67: 205–8
   PubMed Web of Science ®Google Scholar
• Wyllie A. H., Morris R. G., Smith A. L., Dunlop D. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Immunol. 1984; 142: 67–77
   Google Scholar
• Ansari B., Coates P. J., Greenstein B. D., Hall P. A. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol. 1993; 170: 1–8
   PubMed Web of Science ®Google Scholar
• Jonker R. R., Baumann J. G. J., Wijsman J. H., Visser J. W. M. Detection of apoptosis with in situ nick translation. Anal. Cell Pathol. 1992; 4: 111
   Google Scholar
• Stansfeld A. G., Diebold J., Kapanci Y., Kelenyi G., Lennert K., Mioduszewska O., Noel H., Rilke F., Sundstrom C., Van Unnik J. A. M., Wright D. H. Updated Kiel classification for lymphomas. Lancet 1988; i: 292–293
   Google Scholar
• Hell K., Lorenzen J., Hansmann M. L., Fellbaum C., Busch R., Fischer R. Expression of the proliferating cell nuclear antigen in the different types of Hodgkin's disease. Am. J. Clin. Pathol. 1993; 99: 598–603
   PubMed Web of Science ®Google Scholar
• Campo E., Cardesa A., Alos L., Palacin A., Cobarro J., Traserra J., Montserrat E. Non-Hodgkin's lymphomas of nasal cavity and paranasal sinuses: an immunohistochemical study. Am. J. Clin. Pathol. 1991; 96: 184–190
   PubMed Web of Science ®Google Scholar
• Liang R., Todd D., Chan T. K., Chiu E., Choy D., Loke S. L., Ho F. C. Nasal lymphoma: a retrospective analysis of 60 cases. Cancer 1990; 66: 2205–2209
   PubMed Web of Science ®Google Scholar
• Yamanaka N., Harabuchi Y., Sambe S., Shido F., Matsuda F., Kataura A., Ishii Y., Kikuchi K. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects. Cancer 1985; 56: 768–776
   PubMed Web of Science ®Google Scholar
• Ferry J. A., Sklar J., Zukerberg L. R., Harris N. L. Nasal lymphoma: a clinicopathologic study with immunophenotyopic and genotypic analysis. Am. J. Surg. Pathol. 1991; 15: 268–279
   PubMed Web of Science ®Google Scholar
• Ratech H., Burke J. S., Blayney D. W., Sheibani K., Rappaport H. A clinicopathologic study of malignant lymphomas of the nose, paranasal sinuses, and hard palate, including cases of lethal midline granuloma. Cancer 1989; 64: 2525–31
   PubMed Web of Science ®Google Scholar
• Atichartakarn V., Nitiyanant P., Kraiphibul P., Songsiridej N., Clongsusuek P. Lethal midline granuloma and lymphoproliferative disorders. J. Med. Assoc. Thai. 1989; 72: 243–9
   PubMedGoogle Scholar
• Cleary K. R., Batsakis J. G. Sinonasal lymphomas. Ann. Otol. Rhinol. Laryngol. 1994; 103: 911–4
   PubMed Web of Science ®Google Scholar
• Chan J. K., Ng C. S., Lau W. H., Lo S. T. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am. J. Surg. Pathol. 1987; II: 418–29
   Web of Science ®Google Scholar
• Gerdes J., Dallenbach F., Lennert K., Lemke H., Stein H. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Haematol. Oncol. 1984; 2: 365–371
   PubMedGoogle Scholar
• Hall P. A., Richards M. A., Gregory W. M., D'Ardenne A. J., Lister T. A., Stansfeld A. G. The prognostic value of Ki-67 immunostaining in non-Hodgkin's lymphoma. J. Pathol. 1988; 154: 223–235
   PubMed Web of Science ®Google Scholar
• Yamakana N., Harabuchi Y., Kataura A. The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity. Cancer 1992; 70: 2342–2349
   PubMed Web of Science ®Google Scholar
• Leoncini L., Del Vecchio M. T., Megha T., Barbini P., Galieni P., Pileri S., Sabattini E., Gherlinzoni F., Tosi P., Kraft R. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am. J. Pathol. 1993; 142: 755–63
   PubMed Web of Science ®Google Scholar
• Gregory C. D., Dive C., Henderson S., Smith C. A., Williams G. T., Gordon J., Rickinson A. B. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991; 349: 612–4
   PubMed Web of Science ®Google Scholar
• Henderson S., Rowe M., Gregory C., Croom C. D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–15
   PubMed Web of Science ®Google Scholar
• Sinkovics J. G. Programmed cell death (apoptosis) its virological and immunological connections (a review). Acta. Microbiol. Hung. 1991; 38: 321–34
   PubMedGoogle Scholar
• Silins S. L., Sculley T. B. Burkin's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int. J. Cancer 1995; 60: 65–72
   PubMed Web of Science ®Google Scholar
• Hickish T., Robertson D., Clarke P., Hill M., Di Stefano F., Clarke C., Cunningham D. Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. Cancer Res. 1994; 54: 2808–11
   PubMed Web of Science ®Google Scholar
• Takayama S., Sato T., Krajewski S., Kockel K., Irie S., Millan J. A., Reed J. C. Cloning and functional analysis of BAG-1: A novel bcl-2 binding protein with anti-cell death activity. Cell 1995; 80: 279–284
   PubMed Web of Science ®Google Scholar
• Finke J., Fritzen R., Ternes P., Trivedi P., Bross K. J., Lange W., Mertelsmann R., Dolken G. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 1992; 80: 459–69
   PubMed Web of Science ®Google Scholar
• Van Gorp J., Weiping L., Jacobse K., Liu Y. H., Li F. Y., De Weger R. A., Li G. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China. J. Pathol. 1994; 173: 81–7
   PubMed Web of Science ®Google Scholar
• Lorenzen J., Li G., Zhao H. M., Wintzer C., Fischer R., Hansmann M. L. Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues. Virchows Arch. 1994; 424: 593–600
   PubMed Web of Science ®Google Scholar